Support for a TAVR-first approach in patients with concurrent valve and coronary disease
While procedural success rates lag overall, they shine for retrograde crossing
Lower success rates, more hospital MACE seen with poor-quality distal targets
Study shows STEMI protocol closes traditional gaps in care metrics and mortality
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Surrogate decision-making appears to increase risk of serious complications
A sampling of our recent volume and outcomes data
Updated meta-analysis supports personalizing antiplatelet strategies
Cleveland Clinic experience supports widespread adoption at U.S. hospitals
Expert analysis argues that study design may have disadvantaged CABG
A long-overdue technology is poised to reshape practice